Tags

Type your tag names separated by a space and hit enter

COVID-19 and the Heart.
Circ Res. 2020 05 08; 126(10):1443-1455.CircR

Abstract

Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.

Authors+Show Affiliations

From the Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.From the Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Review

Language

eng

PubMed ID

32252591

Citation

Akhmerov, Akbarshakh, and Eduardo Marbán. "COVID-19 and the Heart." Circulation Research, vol. 126, no. 10, 2020, pp. 1443-1455.
Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020;126(10):1443-1455.
Akhmerov, A., & Marbán, E. (2020). COVID-19 and the Heart. Circulation Research, 126(10), 1443-1455. https://doi.org/10.1161/CIRCRESAHA.120.317055
Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020 05 8;126(10):1443-1455. PubMed PMID: 32252591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 and the Heart. AU - Akhmerov,Akbarshakh, AU - Marbán,Eduardo, Y1 - 2020/04/07/ PY - 2020/4/8/pubmed PY - 2020/5/12/medline PY - 2020/4/8/entrez KW - biomarkers KW - cardiovascular diseases KW - coronavirus KW - inflammation KW - myocarditis SP - 1443 EP - 1455 JF - Circulation research JO - Circ Res VL - 126 IS - 10 N2 - Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020. SN - 1524-4571 UR - https://www.unboundmedicine.com/medline/citation/32252591/COVID_19_and_the_Heart_ L2 - https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.317055?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -